Drug sensitivity testing for personalized lung cancer therapy
- PMID: 22295162
- PMCID: PMC3256555
- DOI: 10.3978/j.issn.2072-1439.2011.06.07
Drug sensitivity testing for personalized lung cancer therapy
Conflict of interest statement
No potential conflict of interest.
Similar articles
-
Biomarker Testing for Personalized Therapy in Lung Cancer in Low- and Middle-Income Countries.Am Soc Clin Oncol Educ Book. 2017;37:403-408. doi: 10.1200/EDBK_175243. Am Soc Clin Oncol Educ Book. 2017. PMID: 28561679 Review.
-
Personalized drug testing in a patient with non-small-cell lung cancer using cultured cancer cells from pleural effusion.J Int Med Res. 2020 Sep;48(9):300060520955058. doi: 10.1177/0300060520955058. J Int Med Res. 2020. PMID: 32954884 Free PMC article.
-
Insider information: Testing cancer drug sensitivity for personalized therapy.Genes Dis. 2015 Sep;2(3):219-221. doi: 10.1016/j.gendis.2015.05.004. Epub 2015 Jun 4. Genes Dis. 2015. PMID: 26491709 Free PMC article.
-
Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective.Acta Pharm Sin B. 2018 Jul;8(4):530-538. doi: 10.1016/j.apsb.2018.04.005. Epub 2018 Apr 30. Acta Pharm Sin B. 2018. PMID: 30109178 Free PMC article. Review.
-
Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial.JMIR Res Protoc. 2017 Apr 25;6(4):e52. doi: 10.2196/resprot.7158. JMIR Res Protoc. 2017. PMID: 28442450 Free PMC article.
Cited by
-
Design and construction of translational medicine platform for urologic oncology.Transl Androl Urol. 2012 Mar;1(1):71-5. doi: 10.3978/j.issn.2223-4683.2012.02.04. Transl Androl Urol. 2012. PMID: 26816690 Free PMC article.
-
Next generation patient-derived prostate cancer xenograft models.Asian J Androl. 2014 May-Jun;16(3):407-12. doi: 10.4103/1008-682X.125394. Asian J Androl. 2014. PMID: 24589467 Free PMC article.
References
-
- Travis WD. Pathology of lung cancer. Clin Chest Med. 2002;23:65–81. - PubMed
-
- Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26:3552–9. - PubMed
-
- Dong X, Guan J, English JC, Flint J, Yee J, Evans K, et al. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res. 2010;16:1442–51. - PubMed
LinkOut - more resources
Full Text Sources